AXSM vs. NVO
Compare and contrast key facts about Axsome Therapeutics, Inc. (AXSM) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AXSM or NVO.
Key characteristics
| AXSM | NVO | |
|---|---|---|
| YTD Return | -4.96% | 28.65% |
| 1Y Return | -4.27% | 55.94% |
| 3Y Return (Ann) | 9.03% | 51.35% |
| 5Y Return (Ann) | 26.96% | 43.22% |
| Sharpe Ratio | -0.06 | 1.80 |
| Daily Std Dev | 46.29% | 32.28% |
| Max Drawdown | -86.65% | -71.28% |
| Current Drawdown | -28.80% | -2.08% |
Fundamentals
| AXSM | NVO | |
|---|---|---|
| Market Cap | $3.44B | $572.09B |
| EPS | -$6.45 | $2.86 |
| PEG Ratio | 0.00 | 2.40 |
| Revenue (TTM) | $251.02M | $244.24B |
| Gross Profit (TTM) | $45.94M | $148.51B |
| EBITDA (TTM) | -$244.54M | $117.85B |
Correlation
The correlation between AXSM and NVO is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AXSM vs. NVO - Performance Comparison
In the year-to-date period, AXSM achieves a -4.96% return, which is significantly lower than NVO's 28.65% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AXSM vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AXSM vs. NVO - Dividend Comparison
AXSM has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 0.74%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 0.74% | 0.71% | 0.84% | 0.94% | 1.33% | 1.51% | 1.97% | 1.52% | 2.87% | 0.92% | 1.43% | 1.23% |
Drawdowns
AXSM vs. NVO - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, which is greater than NVO's maximum drawdown of -71.28%. Use the drawdown chart below to compare losses from any high point for AXSM and NVO. For additional features, visit the drawdowns tool.
Volatility
AXSM vs. NVO - Volatility Comparison
Axsome Therapeutics, Inc. (AXSM) has a higher volatility of 11.58% compared to Novo Nordisk A/S (NVO) at 7.57%. This indicates that AXSM's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AXSM vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities